Intestinal mesenchymal cells deposit extracellular matrix in fibrotic Crohn's disease 
of fibrotic strictures in fibrostenosing CD are not well defined. The estimated lifetime risk of surgery for patients with CD is approximately 70% 1, 2 and fibrostenosing disease is the most common surgical indication. Surgery is not only costly for healthcare systems 3 but is associated with unemployment and poorer quality of life scores for patients. 4 Current medical therapies are unable to reverse established fibrosis and the prediction of stricture development remains a significant clinical challenge. Moreover, the rates of progression to stricturing disease have not altered despite the introduction and subsequent widespread use of biological therapy. 5 Intestinal mesenchymal cells play a pivotal role in deposition of extracellular matrix that characterises fibrosis in CD. 6, 7 Manipulating the accumulation and function of intestinal mesenchymal cells is an attractive therapeutic option for fibrostenosing CD. Potential mechanisms of mesenchymal cell accumulation include expansion of the resident cell population, recruitment of bone marrow-derived circulating fibrocytes, and epithelial to mesenchymal transition (EMT). 8 EMT is a process in which epithelial cells lose cellular adhesion and acquire mesenchymal morphology, together with an increased migratory phenotype. Epithelial-specific cellular markers are lost whilst mesenchymal markers are gained. The loss of e-cadherin, a cell adhesion molecule responsible for adherens junction integrity, 9 ,10 appears to be a necessary step for EMT to occur.
11
EMT has been heavily implicated in both cancer progression (type 3 EMT) [12] [13] [14] and the development of tissue fibrosis (type 2 EMT). The latter has been demonstrated in renal, [15] [16] [17] [18] [19] hepatic, [20] [21] [22] pulmonary 23, 24 and cardiac 25, 26 models. Two recent studies of type 2 EMT have provided evidence for the concept of "partial EMT" 27, 28 whereby cells lose epithelial characteristics but promote fibrosis by means other than the active deposition of extracellular matrix within the deeper tissue layers. These include the secretion of exosomes and cytokines to promote the differentiation of fibroblasts to myofibroblasts and the recruitment of bone-marrow derived mesenchymal cells. In one study these transitioning cells were found close to the epithelial layer from which they had originated. 27 This concept of "partial EMT" is thought occur predominantly in type 2, rather than type 3, EMT. 27, 29 It is possible that this is the case in intestinal fibrosis, although comparatively few studies have been performed examining the role of EMT in this setting. Cell fate mapping in a murine colitis model demonstrated double-labelled intestinal epithelial cells for both epithelial-specific and mesenchymal-specific cellular markers. 30 In addition, high levels of nuclear β-catenin localisation and expression of the transcription factor SLUG, which can both be associated with EMT, were reported in human CD intestinal samples. 31 MiRNAs regulate EMT by negative post-transcriptional control of target gene expression. The miR-200 family impacts on fibrosis-related EMT in organs other than the intestine. [32] [33] [34] [35] MiR-200b overexpression leading to suppression of TGFβ-induced EMT alterations has been demonstrated in an intestinal epithelial cell line. 36 In addition, downregulation of the miR-200 family and altered expression of the EMT effectors SNAIL and SLUG has been reported in colonic tissue from patients with CD. 37 In this study, we examined well-characterised intestinal CD specimens for the presence of EMT by quantifying cellular marker expression and related this to the histological degree of fibrosis. We also confirmed dysregulation of the miR-200 family and downstream effectors in fibrotic samples and demonstrate that the former is specific to the intestinal epithelium.
Finally, we assessed serum levels of the miR-200 family in different CD phenotypes.
| METHODS

| Patient recruitment
Patients at Barts Health NHS Trust with a documented history of stricturing ileal CD undergoing surgical resection were recruited. 
| Immunohistochemistry image analysis
Stained slides were scanned with the NanoZoomer 2.0 slidescanner (Hamamatsu, Japan). Tissue areas of interest for each cellular marker were outlined in ImageJ software in order to block out the rest of the image. Predetermined thresholds for pigment colour on the redgreen-blue spectrum, size and circularity were then applied to these areas of interest in order to capture both background cellular counterstaining and positive cellular antibody staining separately (Table S1 ). These thresholds were used consistently across all samples. Images generated by the ImageJ program were also checked visually to ensure staining included in the analysis was truly cellrelated and not simply as a result of cellular debris or tissue artefact.
Extra-epithelial staining of e-cadherin and cytokeratin-18 was measured using three randomly selected fields of lamina propria and submucosa at 20× magnification of each sample and measuring the proportion of positive cellular staining from total counterstaining.
Vimentin staining was measured in 2 randomly selected regions of 100 consecutive surface epithelial cells as well as 3 randomly and qPCR using the miScript system (Qiagen) and a pre-amplification step owing to low RNA concentrations. Fold changes were calculated using the 2 −δδCT method normalised to miR-26b as an endogenous control for miRNA assays and GAPDH for mRNA assays. The miScript system was used for miRNA extracted from serum without a pre-amplification step. The synthetic RNA spike-in, Ce_miR-39_1, was added to aid data normalisation. Analysis of melt curves was undertaken to ensure a single PCR product was 
| Laser capture micro-dissection
| Statistics
Graphpad Prism analysis software was used to perform Student's t tests and Pearson's correlation coefficients as denoted. A P-value <0.05 was considered statistically significant. Experiments were performed in triplicates except for the serum quantifications which were performed in duplicates.
3 | RESULTS
| Patient demographics
The clinical characteristics of patients providing tissue from intestinal resections are shown in Table 1 . All patients presented with either ileal (55.6%) or ileocolonic (44.4%) disease, and all had a stricturing phenotype. Table 2 summarises the clinical characteristics of CD patients from whom serum samples were used for miRNA expression profiling. Both the median age at sample collection and disease duration were higher in the SCD group compared to the NSCD group, although this difference was not statistically significant. This is perhaps intuitive, given that the development of fibrosis usually occurs later in the disease course in CD. CDAI scores were almost identical between the two groups (NSCD and SCD).
Similarly, there was no significant difference in the proportion of patients prescribed systemic 5-ASA, antibiotic, thiopurine or anti-TNFα treatment.
| Quantified expression patterns of cell-specific markers are consistent with EMT in fibrotic CD intestinal tissue
Immunohistochemistry (IHC) staining for the epithelial-specific cellular marker e-cadherin revealed a highly specific epithelial pattern in all sections of nine CD surgical sample pairs ( Figure S1 ). However, not a single cell positive for e-cadherin staining was localised outside of the epithelial architecture (0% for both NSCD and SCD sample groups). Table 3 and Figure 1A and B show the percentages of extra-epithelial cells positively stained for cytokeratin-18 as a proportion of total cells stained for each specimen (raw data are shown in Table S2 ). Positive cellular staining of cytokeratin-18 within the lamina propria and submucosa was observed in 17 of 18 specimens (94%). The mean percentage of positively stained cells was significantly higher in the SCD group (0.49% vs 0.15%; P = 0.043). Representative sample images from IHC staining are shown in Figure 1C -F. Table 3 and Figure 2A and B show the area percentages positively stained for vimentin as a proportion of epithelial area per field. Raw figures for each section are shown in Table S3 . Epithelial expression of the mesenchymal marker vimentin was significantly higher in the SCD group (17.39% vs 6.65%, P = 0.003). Representative IHC images are shown in Figure 2C -H.
| Histological tissue scoring allows objective assessment of fibrosis and inflammation and correlation with EMT marker expression
As expected, all blocks containing stricture had significantly higher total fibrosis scores than blocks containing no stricture (9.55 vs 5.11, P = 0.003; Table 4 , Table S4 ). The mild to moderate scores for NSCD blocks confirmed the field change effect of histological fibrosis progression (Table S4) . No dysplasia was found in any section. Total ulcer scores, used as correlates for inflammation, were not significantly different between the two groups (P = 0.7; Table 4 ). Given the apparent regulatory role of the miR-200 family in EMT, [31] [32] [33] 35 we next sought to measure expression in different intestinal tissue compartments in an independent cohort of SCD and NSCD controls (n = 3 sample pairs). LCM was used to isolate regions of epithelium and submucosa as well as smooth muscle as a control compartment from each tissue section ( Figure S3 ). As predicted RNA yield was low, so standardisation of RNA input involved dissecting a consistent area per tissue compartment (Table S5 shows the areas harvested for each sample; Table S6 shows total area grouped by NSCD and SCD samples). The expression data were also normalised to miR-16 to facilitate comparison of relative expression levels. 
| Epithelial down-regulation of miR-141 is associated with the histological degree of fibrosis in intestinal CD samples
The histological scoring system allowed a comparison of the fibrosis grade to the compartmental expression of the miR-200 family in the cohort of SCD patients used for the LCM study. A negative correlation was observed between epithelial miR-141 expression and subserosal fibrosis score (n = 3 sample pairs, R 2 = 0.75, P = 0.02, Figure 3E ). Increased cycle threshold values (and therefore reduced There is a significant increase in the percentage of area positively stained for vimentin in the strictured specimens compared to the non-strictured specimens (P = 0.003). Bars represent standard error of the mean (SEM). **P < 0.01. Panels C-H, immunohistochemical staining demonstrating specific positivity for vimentin within the lamina propria and submucosa of non-strictured (C, ×0.6; D, ×20; E, ×20) and strictured (F, ×0.6; G, ×20; H, ×20) intestinal sections from patients with CD. Panels D and E show the areas of surface epithelium and crypts highlighted in panel C by the black rectangle, respectively, at a higher magnification. Panels G and H show the areas of surface epithelium and crypts highlighted in panel F by the black rectangle, respectively, at a higher magnification. Both the surface epithelium and crypt epithelium show higher positive staining in the strictured specimens than in the non-strictured specimens expression) of miR-141 appeared to be associated with higher subserosal fibrosis scores, which were composite scores of both the extent and severity of subserosal fibrosis. No significant correlation was observed between the compartmental expression of any other miRNA and histological fibrosis score parameter (Table S7 ). 
|
| The miR-200 family is lowly expressed in sera of CD patients and profiles do not differ between disease phenotypes
The observation that the miR-200 family is down-regulated within the intestinal epithelium in SCD is potentially clinically relevant for the development of biomarkers of intestinal fibrosis in CD, in that the epithelium is readily sampled by endoscopic mucosal biopsy.
However, non-invasive testing is clearly more desirable given the potential risks with endoscopic procedures and the potential inaccessibility of small intestinal lesions. Therefore, given that serum miRNA profiles can be stable over time and assayed successfully, 31,37,41 the expression of the miR-200 family in the sera of patients with CD was studied, with the aim to assess whether alterations in levels in patients with SCD could be found. An independent cohort of 42 CD patients ( Table 2) 
| DISCUSSION
Although published data suggest a contribution of EMT to the development of intestinal fibrosis in mouse models, 30 there are only very few reports of cellular EMT events in human CD. 31, 32, 37 This is mainly due to the inherent difficulties associated with such studies:
well-phenotyped ex vivo samples are necessary and most commer- Nine sample sets of archived small intestinal specimens from patients with CD were graded by an independent gastrointestinal histopathologist who was blinded to clinicopathological details and given total fibrosis and total ulcer scores. The mean total fibrosis scores were significantly higher in the stricture sets than the non-stricture sets, with no significant difference in the total ulcer scores between the two groups.
thought to occur more frequently in fibrosis-related EMT than cancer-related EMT. 27, 29 The significant alterations in EMT cellular marker expression between NSCD and SCD tissue occurred in sample groups between which objective inflammatory scores were not significantly different.
This contrasts with previous data showing reduced e-cadherin expression and increased vimentin expression in inflamed colonic mucosal biopsy samples from patients with IBD. 36 It is unclear RT-qPCR was performed on RNA extracted from eight matched sample pairs of strictured (grey bars) and non-strictured (black bar) small intestinal tissue from patients with fibrostenosing CD. Fold changes were calculated using the 2 −δδCT method normalised to GAPDH. ZEB1 was found to be significantly up-regulated (P = 0.035). Three other transcription factors
were not significantly up-regulated: ZEB2 (P = 0.259), SNAIL (P = 0.101), TWIST (P = 0.173). Bars represent mean standard error. *P < 0.05 whether the specimens in that study also had evidence of fibrosis, although this would seem less likely given that patients with UC were included and all samples were colonic, rather than ileal, in origin. In addition, the samples in the present study were chosen carefully to avoid including dysplasia or established cancer, given the well-characterised association of EMT with gastrointestinal cancer progression. Therefore, it can be assumed that the EMT marker alterations demonstrated here were not being driven by malignancy or inflammation.
The histological fibrosis scoring system used here was not vali- One way ANOVA testing revealed no significant differences between the clinical groups for any member of the miR-200 family nor the control U6. Mir-429 was excluded from this analysis as correlation between duplicate readings was poor. AU, arbitrary units; HC, healthy controls; NSCD, non-stricturing Crohn's disease; SCD, stricturing Crohn's disease
Loss of e-cadherin and subsequent cellular adhesion is a hallmark of EMT 16, 29, 44 and this may occur under the control of the miR-200 family via the transcription factors ZEB1 and perhaps also ZEB2, SNAIL and TWIST; this loss may be an "EMT trigger" in this setting. family is likely to be functionally relevant in CD fibrosis, but does not appear to be amenable to non-invasive serum sampling for assessment of fibrotic burden or monitoring therapeutic intervention.
The focus of future research therefore should be on improving the understanding of the processes underpinning intestinal fibrosis and identifying potential therapeutic targets.
In conclusion, our results indicate the occurrence of EMT in fibrotic intestinal CD tissue, and that this occurs independently of the effect of inflammation. Additional work is now required to confirm these findings using a wide range of epithelial and mesenchymal markers. The miR-200 family, known regulators of EMT in other organs, are dysregulated in fibrotic CD intestine, and this dysregulation is specific to the epithelium. Functional studies, together with further larger scale studies using similarly well-phenotyped samples are warranted.
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